Osmohale® in United Kingdom

img productIreland

Welcome to the United Kingdom homepage

The mannitol challenge test (Osmohale®) is an indirect osmotic bronchial challenge test that can be used to identify bronchial hyperresponsivesness, a key clinical feature of respiratory conditions such as asthma.

Osmohale is manufactured by Pharmaxis Ltd (Frenchs Forest, Sydney Australia) and is available as a standardised test kit containing pre-filled mannitol capsules and a hand held dry powder inhaler.

During a mannitol challenge test, the subject inhales increasing doses of mannitol with their lung function (forced expiratory volume in one second- FEV1) measured after each dose to determine the level of bronchial hyperresponsiveness.

The mannitol challenge test should only be performed by a suitably trained healthcare professional. Please refer to the approved product information or summary of product characteristics for your country prior to performing this challenge test.

Please refer to the Approved Osmohale Product Information(PI) and Consumer Medicine Information attached below.

For more information about Osmohale in the United Kingdom please contact;

Pharmaxis Europe Limited

To Order:

From the 1st May 2020 the supply of Osmohale for the United Kingdom will change from Mawdsleys Brooks & Co to Arvato Bertelsmann.

For orders up to 30th April 2020:

Phone: 0114 254 3585

Fax:  0114 242 5573

Email: sheffield.orders@mpwpharma.co.uk

For orders from the 1st May 2020:

Phone: 0800 2794468

Fax:  0800 2794469

Email:   orders.uk@pharmaxis.com

 

Medical Information:

Email: medinfo.uk@pharmaxis.com

Announcement icon

COVID-19: Information for Respiratory Laboratories and Pharmacies